Impact of Substance Dependence and Dual Diagnosis on the Quality of Life of Heroin Users Seeking Treatment |
| |
| Authors: | Mònica Astals Antònia Domingo-Salvany Claudio Castillo Buenaventura Jordi Tato José M Vazquez Rocío Martín-Santos |
| |
| Affiliation: | 1. Department of Psychiatry and Drug Abuse and Psychiatric Research Group, Hospital del Mar (IAPS) and Institut Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain;2. Doctorat en Psiquiatria i Psicologia Mèdica. Departament de Psiquiatria i Medicina Legal, Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain;3. Health Services Research Unit, Institut Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain;4. Centre d'Atenció i Seguiment Creu Roja, Barcelona, Spain;5. Centre d'Atenció i Seguiment Sants, Barcelona, Spain |
| |
| Abstract: | In 189 opioid-dependent subjects on methadone maintenance treatment in Barcelona (Spain), we assessed the prevalence of co-occurrence substance use and non-substance-use disorders (dual diagnosis) by the Psychiatric Research Interview for Substance and Mental Disorders [PRISM], and the impact on quality of life (HRQoL) by the SF-12 (PCS-12 and MCS-12 scales). Rates of substance and non-substance-use diagnoses were 59% and 32%, respectively. Mean scores for PCS-12 and MCS-12 were 44.1 ± 10.1 and 39.9 ± 11.7, without differences by presence or absence of dual diagnosis. Heroin users on methadone treatment showed a high prevalence of dual diagnosis and a very impaired HRQoL. |
| |
| Keywords: | heroin dependence dual diagnosis psychiatric comorbidity quality of life methadone |
|
|
